3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Sarcopenia
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Motor Activity
1
Interventions
venetoclax
157
Cytarabine
117
Cyclophosphamide
110
Specimen Handling
103
Azacitidine
103
fludarabine
89
Biopsy
78
Rituximab
50
Methotrexate
45
Daunorubicin
45
fludarabine phosphate
41
Vincristine
38
Dexamethasone
37
Injections
36
Magnetic Resonance Spectroscopy
35
Decitabine
35
Granulocyte Colony-Stimulating Factor
32
blinatumomab
31
Mycophenolic Acid
30
Idarubicin
30
Whole-Body Irradiation
29
ibrutinib
27
Tacrolimus
27
Prednisone
27
Etoposide
27
Doxorubicin
27
Busulfan
27
acalabrutinib
24
Melphalan
24
Filgrastim
24
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Wearable Electronic Devices
×
Other hematologic neoplasm
×
90 days
×
Clear all
NCT07325305
2026-04-13
PROTECT
Murdoch Childrens Research Institute
Phase NA
Recruiting
60 enrolled